contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


upcoming-markerless-solution-by-qualisys-to-redefine-athlete-insights

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Qualisys är ett teknikbolag engagerat i utveckling och försäljning av helhetssystem inom specialistområdet motion capture. Bolaget har en egenutvecklad teknologi för insamling, bearbetning och analys av rörelsedata. Försäljningen sker inom tre affärsområden; Life sciences, Engineering och Entertainment. Teknologin appliceras exempelvis inom sportbiomekanik, medicinteknik, industriella applikationer och animering. Huvudkontoret ligger i Göteborg.

Qualisys

Gothenburg, Sweden – Qualisys, a global leader in motion capture technology, is preparing to launch a groundbreaking solution that promises to redefine how elite sports teams track and analyze...

<div class="mfn-preamble"><p><strong>Gothenburg, Sweden – Qualisys, a global leader in motion capture technology, is preparing to launch a groundbreaking solution that promises to redefine how elite sports teams track and analyze athlete performance. The company’s proprietary, end-to-end markerless solution for athlete baseline testing, OnTraq, is set to debut in an exclusive beta program as it introduces an innovative approach to performance tracking.</strong></p></div><div class="mfn-body"><p>Designed with usability and precision in mind, OnTraq introduces an intuitive platform that allows teams to efficiently establish individual athlete baselines. By focusing on user-friendly design and streamlined workflows, it ensures seamless integration into regular sports training routines.</p><p>“Qualisys has always prided itself on providing solutions of quality and high accuracy. When we approached markerless technology, we upheld the same motive,” said Oskar Lindh, Product Owner of OnTraq. “It combines advanced, reliable performance insights with ease of use, addressing the critical needs of sports professionals.”</p><p>The timing of the OnTraq release reflects Qualisys' focus on quality and technical precision, even amidst growing industry pressures to adopt markerless technology quickly. By carefully refining the product and engaging in collaborative beta testing with elite teams, Qualisys honors its historical commitment to delivering superior solutions. This deliberate approach ensures that OnTraq not only meets but exceeds the high standards set by the company’s legacy.</p><p>The upcoming beta program will invite select teams to experience OnTraq firsthand, shaping the final product through their valuable feedback. Further details about OnTraq will be revealed as the product moves closer to official launch. Those interested in staying informed or joining the early access program can visit qualisys.com/campaign/ontraq.</p><p><strong>Contacts</strong></p><p>PRODUCT MARKETING MANAGER, QUALISYS<br>Stephanie Knustrom</p><ul><li><a rel="noopener" href="mailto:stephanie.knustrom@qualisys.com">stephanie.knustrom@qualisys.com</a></li><li>&nbsp;+1(847)212-3065</li></ul></div><div class="mfn-footer mfn-about mfn-4c4480237d90"><p><strong class="mfn-heading-1">About Qualisys Holding AB (publ)</strong><br>Qualisys is a leading provider of motion capture technology and has a long history of supplying research, engineering, entertainment, and sports facilities with high-end camera systems and expertise in capturing and analyzing movements. Qualisys offers a wide range of products and services with its headquarter in Gothenburg, Sweden, and operations in Chicago, Singapore and Shanghai. Qualisys is certified according to ISO 9001:2015, the clinical products are compliant with Medical Device Directive 93/42/EEC and have FDA clearance (K171547).</p><p>Qualisys is listed on Nasdaq First North Premier Growth Market. The company’s Certified Adviser is Svensk Kapitalmarknadsgranskning AB.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/7eeb9695-a1c0-4eaa-904d-f5dfb4eda911/upcoming-markerless-solution-by-qualisys-to-redefine-athlete-insights.pdf" class="mfn-generated mfn-primary">Upcoming Markerless Solution by Qualisys to Redefine Athlete Insights</a></p></div>

Upcoming Markerless Solution by Qualisys to Redefine Athlete Insights

USA:s Black Week ledde till överraskande inköp

Uppgångsvecka bakom oss, Tyskland gick vidare med sin megabudget

Finlands ekonomiska tillväxt: ”Varje dag och varje natt tänker jag på dig”

Nedgångsvecka bakom oss, AI-oron når även obligationsmarknaden

USA:s sysselsättningssiffror: En ljusglimt i Feds fyr